Wu Yin currently serves as the Executive Director at Schrödinger, overseeing Immunology & Inflammation Diseases and leading early clinical assets since May 2018. Previously, Wu held various senior roles within Schrödinger, including Senior Director and Senior Research Leader, contributing significantly to early clinical development and oncology programs. Before joining Schrödinger, Wu was the Director of Business Development at Pharmaron, facilitating collaborations for Phase I and early Phase II studies. Wu's career at Merck spanned from 2009 to 2017, culminating as Principal Scientist and leading teams focused on cardiometabolic diseases. Wu began academic training at the University of Pennsylvania, earning a Ph.D. in Pharmacology, and holds both a Master's and Bachelor's degree in Neuropharmacology and Animal Physiology from Peking University, respectively.
This person is not in the org chart
This person is not in any teams
This person is not in any offices